Is Liraglutide (Saxenda / Victoza) legal?
Liraglutide (Saxenda / Victoza) is an FDA approved drug. For drug-tested athletes it is not on the WADA prohibited list. Yes, primary care, endocrinology, and obesity-medicine specialists prescribe widely.. Legal status depends on your country and changes over time. This reflects US status at the time of writing and is not legal or medical advice.
Regulatory status
- FDA: Approved as Victoza (2010, type 2 diabetes) and Saxenda (2014, obesity). Both Novo Nordisk.
- WADA: Not listed
- Prescription: Yes, primary care, endocrinology, and obesity-medicine specialists prescribe widely.
References
- A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management (SCALE Obesity) — Pi-Sunyer X et al., NEJM, 2015
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes (LEADER) — Marso SP et al., New England Journal of Medicine, 2016
- Victoza (liraglutide) — Drugs@FDA approval record (ApplNo 022341) — FDA, Drugs@FDA
Pepdex is an editorial reference, not medical advice. Peptides vary in legal and approval status by country, many are research compounds without full human safety data. Talk to a qualified clinician before starting anything.
More on Liraglutide (Saxenda / Victoza)
Last updated 2026-06-06.